a nonsignificant trendP = .17
During the study period, there was a nonsignificant trend toward fewer deaths (secondary endpoint) in the CSP group compared to the CP group (25% vs 37%; HR 0.71, 95% CI 0.43–1.15, P = .17).
During the study period, there was a nonsignificant trend toward fewer deaths (secondary endpoint) in the CSP group compared to the CP group (25% vs 37%; HR 0.71, 95% CI 0.43–1.15, P = .17).
The incidence of individual secondary endpoint of HFH decreased in the CSP group compared to CP (39% vs 50%; HR 0.72, 95% CI 0.49–1.09, P = .12) but did not reach statistical significance ( Figure 3 , Table 5 ).